# China NMPA Drug Inspection - Marketing Authorization Holder: Shenzhen Jiurui Health Technology Development Co., Ltd.; Trustee: Sinopharm Group Guangdong Global Pharmaceutical Co., Ltd. - Atorvastatin calcium dispersible tablets

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/marketing-authorization-holder-shenzhen-jiurui-health-technology-development-co-ltd-trustee-sinopharm-group-guangdong-global-pharmaceutical-co-ltd/5540c13d-2a2a-4e9c-963d-64b8db667431/
Source feed: China

> China NMPA drug inspection for Marketing Authorization Holder: Shenzhen Jiurui Health Technology Development Co., Ltd.; Trustee: Sinopharm Group Guangdong Global Pharmaceutical Co., Ltd. published June 17, 2021. Drug: Atorvastatin calcium dispersible tablets. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Guangdong Provincial Drug Administration's Announcement Regarding Drug Sampling and Inspection Information (Issue 5, 2021)
- Company Name: Marketing Authorization Holder: Shenzhen Jiurui Health Technology Development Co., Ltd.; Trustee: Sinopharm Group Guangdong Global Pharmaceutical Co., Ltd.
- Publication Date: 2021-06-17
- Drug Name: Atorvastatin calcium dispersible tablets
- Inspection Finding: Compliant with drug standards

Company: https://www.globalkeysolutions.net/companies/marketing-authorization-holder-shenzhen-jiurui-health-technology-development-co-ltd-trustee-sinopharm-group-guangdong-global-pharmaceutical-co-ltd/85a49333-5537-44c7-832c-447541d683d6/